How excessive fructose consumption fuels Obesity and Type 2 Diabetes

pharmanewsdaily- January 27, 2025 0

In recent years, the link between high fructose intake and the prevalence of obesity and type 2 diabetes has emerged as a critical public health ... Read More

Inversago Pharma’s INV-202 shows promising effects in metabolic syndrome

Pallavi Madhiraju- June 24, 2023 0

Inversago Pharma, a Canadian clinical stage company, has announced positive data from its Phase 1b trial for INV-202, a peripherally-acting CB1r blocker, which is being ... Read More